How would you approach the management of a patient with oligometastatic NSCLC characterized by a LUL mass and a solitary adrenal metastasis, assuming a good performance status?

Induction chemotherapy (platinum-doublet x3 cycles) followed by lobectomy, mediastinal lymph node dissection, and adrenalectomy if no progression after induction chemotherapy.

Reference: Gomez DR et al, Lancet Oncology 2016